MKI67 and neoplasm: In line with this observation, we found an increase in proliferating (Ki67+) and granzyme B-expressing (cytotoxic) P1A-specific, tumor-infiltrating CTLs in mice with heterologous artARENA immunotherapy (Figures 7I and 7J).